OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
January 07, 2021
Why it’s important to integrate patient assistance programs for cell and gene therapies into the overall clinical development plan.
October 01, 2020
2020 is the year of reimagination.
August 10, 2020
As the world determines how best to function in a COVID-19 world, it is all but certain that some level of safety measures will continue for the foreseeable future.
April 30, 2020
New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
January 31, 2020
The foundation of a strong rare disease marketing program must be built on the comprehensive knowledge of how the life-altering disease impacts all areas of a patient’s life.
October 01, 2019
The rise of digital has enhanced our ability to personalize our marketing messages and engage our target audiences more effectively